Lineage Cell Therapeutics, Inc. Available-for-sale Securities
Lineage Cell Therapeutics, Inc. (LCTX) had Available-for-sale Securities of $1.34 million as of 2017-12-31, per its 10-K filed 2018-03-15.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2018-03-15
- 2017-12-31: Available-for-sale Securities $1.34M.
- 2017-09-30: Available-for-sale Securities $1.51M.
- 2017-06-30: Available-for-sale Securities $1.22M.
- 2017-03-31: Available-for-sale Securities $915.00K.
| Period end | Available-for-sale Securities |
|---|---|
| 2017-12-31 | $1.34M 10-K · filed 2018-03-15 |
| 2017-09-30 | $1.51M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $1.22M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $915.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $627.00K 10-K · filed 2018-03-15 |
| 2016-09-30 | $903.00K 10-Q · filed 2016-11-04 |
| 2016-06-30 | $619.00K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $829.00K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $753.00K 10-K · filed 2017-03-16 |
| 2014-12-31 | $3.00K 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |